BioAge Labs Inc. (BIOA)
Company Description
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.
The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging.
Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults.
It also develops BGE-100, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation.
The company was incorporated in 2015 and is based in Richmond, California.
| Country | United States |
| IPO Date | Sep 26, 2024 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 62 |
| CEO | Dr. Kristen Fortney Ph.D. |
Contact Details
Address: 1445A South 50th Street Richmond, California United States | |
| Website | https://bioagelabs.com |
Stock Details
| Ticker Symbol | BIOA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001709941 |
| CUSIP Number | 09077V100 |
| ISIN Number | US09077V1008 |
| Employer ID | 47-4721157 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Kristen Fortney Ph.D. | Co-Founder, Chief Executive Officer, President, Treasurer, Secretary & Director |
| Dr. Dov A. Goldstein M.B.A., M.D. | Chief Financial Officer |
| Eric Morgen M.D. | Co-Founder, Chief Operating Officer & Director |
| BJ Sullivan Ph.D. | Chief Strategy Officer |
| Dr. Carrie-Lynn Langlais Furr | Senior Vice President of Regulatory Affairs |
| Dr. Paul D. Rubin M.D. | Chief Medical Officer & Executive Vice President of Research |
| Dr. Peng Leong M.B.A., Ph.D. | Chief Business Officer & Therapeutic Area Head of Brain Aging |
| Julie Gammelgard | Senior Vice President of People |
| Justin Rebo | Senior Vice President of Translational Aging Biology |
| Rusty Montgomery Ph.D. | Senior Vice President of Research |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 20, 2025 | S-8 | Filing |
| Mar 20, 2025 | 10-K | Annual Report |
| Mar 20, 2025 | 8-K | Current Report |
| Mar 10, 2025 | 4/A | [Amend] Filing |
| Mar 10, 2025 | 4 | Filing |
| Feb 25, 2025 | 4/A | [Amend] Filing |
| Feb 20, 2025 | 4 | Filing |
| Feb 20, 2025 | 4 | Filing |
| Feb 20, 2025 | 4 | Filing |
| Feb 20, 2025 | 4 | Filing |